Tenaya Therapeutics, INC. (TNYA) SEC Filings — 2025

Filings

• Tenaya Therapeutics, INC. 8-K Filing — 8-K · Dec 12, 2025
• Tenaya Therapeutics Files 8-K Report — 8-K · Dec 11, 2025
• Tenaya Narrows Losses, Boosts Cash Amid R&D Streamlining — 10-Q · Nov 10, 2025
• Tenaya Therapeutics, INC. 8-K Filing — 8-K · Nov 7, 2025
• Tenaya Narrows Q2 Loss, Boosts Cash with $100M Offering — 10-Q · Aug 6, 2025
• Tenaya Therapeutics Files 8-K on Shareholder Votes — 8-K · May 30, 2025
• Tenaya Therapeutics Files Q1 2025 10-Q — 10-Q · May 7, 2025
• Tenaya Therapeutics Faces Delisting Concerns — 8-K · Apr 18, 2025
• Tenaya Therapeutics Files 2025 Proxy Statement — DEF 14A · Apr 17, 2025
• Tenaya Therapeutics Reports Exit/Disposal Costs — 8-K · Mar 28, 2025
• Tenaya Therapeutics Files 2024 10-K — 10-K · Mar 10, 2025
• Tenaya Therapeutics Files 8-K with Material Agreement — 8-K · Mar 4, 2025
• Tenaya Therapeutics Announces Board and Executive Compensation Changes — 8-K · Feb 7, 2025
• Tenaya Therapeutics Appoints New CMO, Dr. Cook — 8-K · Jan 28, 2025